Cytoprotective activities have been reported for various species across different genera (
10,
11), including the genus
Artemisia (
7,
12).
In a recent study, the neuroprotective effects of date palm (
Phoenix dactylifera L.) pollen (DPP) and fluvoxamine maleate (Flv) against H
2O
2-induced oxidative damage in PC12 cells were compared. The combined suppression of oxidative stress by DPP and Flv via the Nrf2 and sigma-1 signaling pathways suggested that these pretreatment regimens could be an effective modality for preventing neurodegenerative damage in an animal neurotoxicity model (
11).
In the present work, the protective activity of various fractions of the PE extract of
A. turcomanica in PC12 cells was investigated. A previous study examined the cytoprotective activity of different extracts of
A. turcomanica in this cell line. The PE extract showed the most significant potential for reducing free radicals (123.3% reduction in ROS levels) and inhibiting caspase-3 activity (74.15% reduction in activity). The results suggested that the PE extract protected PC12 cells against apoptosis, probably via extrinsic pathways. The reduction in ROS levels, preservation of MMP, and decreased caspase-3 activity observed in the present study suggest that the PE extract of
A. turcomanica may exert neuroprotective effects primarily through modulation of the intrinsic mitochondrial apoptotic pathway. Petroleum ether fractions are typically enriched in lipophilic phytochemicals, including terpenoids, sesquiterpene lactones, flavonoid aglycones, and phytosterols, which are known to possess strong antioxidant and membrane-stabilizing properties (
13). These compounds may directly scavenge ROS or enhance endogenous antioxidant mechanisms, such as the Nrf2/ARE pathway, leading to the upregulation of cytoprotective enzymes, including HO-1, SOD, and catalase (
14).
By reducing oxidative stress, these metabolites may help maintain mitochondrial integrity and prevent the opening of the mitochondrial permeability transition pore (mPTP), thereby preserving MMP. Stabilization of MMP is critical for maintaining ATP production and preventing the release of cytochrome c into the cytosol. Suppression of cytochrome c release consequently inhibits downstream activation of caspase-9 and executioner caspase-3, ultimately preventing apoptosis (
15). No previous phytochemical study has investigated the PE extract of
A. turcomanica. However, acetylenes, coumarins, flavonoids, acetophenones, and terpenoids are known as the main secondary metabolites present in the genus
Artemisia (
1).
Thin-layer chromatography analysis of the more potent fractions of the PE extract suggested that they are rich in terpenoids and steroids. There was no evidence of a significant presence of coumarins or alkaloids in the selected PE extract fractions. These results were consistent with previous data indicating the presence of terpenoids and widespread sterols in
A. turcomanica (
5). Steroids and terpenoids are plant secondary metabolites that have shown promising activity against neurodegenerative disorders (
16,
17). Some isolated terpenoids from the genus
Artemisia have shown neuroprotective effects in an in vivo model of Alzheimer disease or a promotive effect on NGF-induced neurite outgrowth in PC12 cells (
18,
19). Recently, a known acetophenone in this genus (
20) showed regulatory effects on the inflammatory microenvironment after spinal cord injury. This effect was exerted through inhibition of the NF-κB signaling pathway (
21). A comprehensive phytochemical study of the PE extract of
A. turcomanica should be undertaken to isolate and identify the bioactive phytochemicals.
5.1. Conclusions
The selected fractions of the PE extract of A. turcomanica had significant in vitro protective effects against oxidative stress. They inhibited ROS generation, MMP reduction, and caspase-3 activity in PC12 cells. Bio-guided isolation of phytoconstituents in the PE extract of A. turcomanica and investigation of their mechanisms of action can be considered the next steps in this research. In addition, well-designed in vivo experiments are essential to determine the efficacy, safety, and bioavailability of these fractions in a whole-organism context, which is necessary before any meaningful extrapolation to human applications can be made.